Clinical Trials Directory

Trials / Unknown

UnknownNCT02417883

Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease

Furosemide Stress Test as a Predictor of Tubular Atrophy and Interstitial Fibrosis in Patients With Chronic Kidney Disease

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In kidney diseases, tubule-interstitium has become much more relevant, as formerly only the glomerulus was considered to have the main importance. Kidney's tubular atrophy and interstitital fibrosis is now recognized as long term prognostic value. We aim to evaluate the function of the kidney's tubule-interstitium through furosemide excretion after intravenous administration of this drug, and correlate the rate of excretion of furosemide with interstitial fibrosis findings in scheduled kidney biopsy for patients with chronic kidney disease.

Detailed description

All patients scheduled for kidney biopsy will be invited to participate in a standard isovolemic furosemide stress test before the biopsy procedure. The latter will consist in 1.5 miligrams per kilogram of weight of intravenous furosemide administration, with urinary output follow up and measurement. The urinary output will be replaced intravenously with normal saline to avoid dehydration and/or hypotension. A standard 5ml sample of blood will be taken before the test and aliquots of urine before and after furosemide administration will be frozen. After completion of the formely mentioned test, patients will proceed to their scheduled kidney biopsy along with interventions considered appropiate by their attending physician. Kidney biopsy sample will be examined by histopathology service and the degree of interstitial fibrosis will be described. The degree of fibrosis will be correlated with the degree furosemide excretion and urinary output.

Conditions

Interventions

TypeNameDescription
DRUGFurosemideEvaluate urinary excretion rate fo furosemide

Timeline

Start date
2015-04-01
Primary completion
2016-04-01
Completion
2017-04-01
First posted
2015-04-16
Last updated
2015-04-16

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02417883. Inclusion in this directory is not an endorsement.